RetinAI: RetinAI and FVS co-developed solution obtains CE-MDR Certification

LuxIA®, an AI algorithm for Diabetic Retinopathy screening codeveloped by RetinAI and Fundación Ver Saludhas successfully received CE-MDR certification as a Class IIb medical device under the European Union Medical Device Regulation. The certification was granted through Ikerian AG, RetinAI's parent company.